Tissue engineering in plastic reconstructive surgery

被引:25
作者
Walgenbach, KJ
Voigt, M
Riabikhin, AW
Andree, C
Schaefer, DJ
Galla, TJ
Stark, GB
机构
[1] Univ Freiburg, Dept Plast & Hand Surg, D-79106 Freiburg, Germany
[2] Valley Tissue Engn Ctr, Freiburg, Germany
来源
ANATOMICAL RECORD | 2001年 / 263卷 / 04期
关键词
tissue engineering; plastic surgery; angiogenesis; biomaterials; gene therapy;
D O I
10.1002/ar.1117
中图分类号
R602 [外科病理学、解剖学]; R32 [人体形态学];
学科分类号
100101 ;
摘要
Tissue engineering (TE) is a new interdisciplinary field of applied research combining engineering and biosciences together with clinical application, mainly in surgical specialities, to develop living substitutes for tissues and organs. Tissue engineering approaches can be categorized into substitutive approaches, where the aim is the ex vivo construction of a living tissue or organ similar to a transplant, vs. histioconductive or histioinductive concepts in vivo. The main successful approaches in developing tissue substitutes to date have been progresses in the understanding of cell-cell interactions, the selection of appropriate matrices (cell-matrix interaction) and chemical signalling (cytokines, growth factors) for stimulation of cell proliferation and migration within a tissue-engineered construct. So far virtually all mammalian cells can be cultured under specific culture conditions and in tissue specific matrices. Future progress in cell biology may permit the use of pluripotent stem cells for TE. The blueprint for tissue differentiation is the genome: for this it is reasonable to combine tissue engineering with gene therapy. The key to the progress of tissue engineering is an understanding between basic scientists, biochemical engineers, clinicians, and industry. Anat Rec 263:372-378, 2001. (C) 2001 Wiley-Liss, Inc.
引用
收藏
页码:372 / 378
页数:7
相关论文
共 41 条
[1]   Angiogenic growth factors: A review for tissue engineering [J].
Ahrendt, G ;
Chickering, DE ;
Ranieri, JP .
TISSUE ENGINEERING, 1998, 4 (02) :117-130
[2]   IN-VIVO TRANSFER AND EXPRESSION OF A HUMAN EPIDERMAL GROWTH-FACTOR GENE ACCELERATES WOUND REPAIR [J].
ANDREE, C ;
SWAIN, WF ;
PAGE, CP ;
MACKLIN, MD ;
SLAMA, J ;
HATZIS, D ;
ERIKSSON, E .
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, 1994, 91 (25) :12188-12192
[3]   SYNERGISTIC EFFECT OF VASCULAR ENDOTHELIAL GROWTH-FACTOR AND BASIC FIBROBLAST GROWTH-FACTOR ON ANGIOGENESIS IN-VIVO [J].
ASAHARA, T ;
BAUTERS, C ;
ZHENG, LP ;
TAKESHITA, S ;
BUNTING, S ;
FERRARA, N ;
SYMES, JF ;
ISNER, JM .
CIRCULATION, 1995, 92 (09) :365-371
[4]   Isolation of putative progenitor endothelial cells for angiogenesis [J].
Asahara, T ;
Murohara, T ;
Sullivan, A ;
Silver, M ;
vanderZee, R ;
Li, T ;
Witzenbichler, B ;
Schatteman, G ;
Isner, JM .
SCIENCE, 1997, 275 (5302) :964-967
[5]  
BACH AD, 1999, CELLS TISSUES ORGANS, V116, P78
[6]   SITE-SPECIFIC THERAPEUTIC ANGIOGENESIS AFTER SYSTEMIC ADMINISTRATION OF VASCULAR ENDOTHELIAL GROWTH-FACTOR [J].
BAUTERS, C ;
ASAHARA, T ;
ZHENG, LP ;
TAKESHITA, S ;
BUNTING, S ;
FERRARA, N ;
SYMES, JF ;
ISNER, JM .
JOURNAL OF VASCULAR SURGERY, 1995, 21 (02) :314-325
[7]   In vitro reconstruction of a human capillary-like network in a tissue-engineered skin equivalent [J].
Black, AF ;
Berthod, F ;
L'Heureux, N ;
Germain, L ;
Auger, FA .
FASEB JOURNAL, 1998, 12 (13) :1331-1340
[8]   THE VASCULAR ENDOTHELIAL-CELL AS A VEHICLE FOR GENE-THERAPY [J].
CALLOW, AD .
JOURNAL OF VASCULAR SURGERY, 1990, 11 (06) :793-798
[9]  
FOLKMAN J, 1971, NEW ENGL J MED, V285, P1182
[10]   ANGIOGENESIS IN CANCER, VASCULAR, RHEUMATOID AND OTHER DISEASE [J].
FOLKMAN, J .
NATURE MEDICINE, 1995, 1 (01) :27-31